Toleriane Ultra Reno in Allergic Subjects With Skin Intolerance to Their Usual Cosmetic
Evaluation of Toleriane Ultra Reno in Allergic Subjects Having Skin Intolerance to Their Usual Cosmetic Care for One Month
1 other identifier
observational
109
1 country
1
Brief Summary
Sensitive skin is a subjective cutaneous hyper-reactivity to environmental factors. People report exaggerated reactions when their skin, especially on the face, is in contact with substances such as cosmetics. For this reason, Toleriane Ultra has been developed to limit the risk of allergy and relieve skin discomfort. The study aims at demonstrating that Toleriane Ultra is well tolerated in participants with allergic background and having experienced former intolerance to their cosmetic or toiletries routine, and improves skin sensitivity in such individuals. This open-labeled, multicenter study was conducted under dermatological control in Caucasian subjects above 16 years of age with an allergic background and intolerance to cosmetics lasting for at least 2 years prior to inclusion. The dermocosmetic product was to be applied on the entire face twice daily for 28 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2021
CompletedFirst Submitted
Initial submission to the registry
June 17, 2022
CompletedFirst Posted
Study publicly available on registry
August 4, 2022
CompletedAugust 4, 2022
August 1, 2022
4 months
June 17, 2022
August 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
change in cutaneous acceptability
evaluation of global tolerance by investigator and participants on a 4-point scale
Change from baseline to Day28
change in cutaneous reactivity score
cutaneous reactivity score on a 4-point scale (non stinging, mild stinging sensation, moderate stinging sensation, severe stinging sensation) before and after product use with a stinging test
Change from baseline to Day28
change in Sensiscore
questionnaire on frequency and intensity of functional signs on the face by self-assessment on a 5-point scale
Change from baseline to Day28
change in composite score
questionnaire on pruritus, redness, burning and tingling by self-assessment on a 4-point scale
Change from baseline to Day28
change in transepidermal water loss
transepidermal water loss measurements before and after product use with a Tewameter
Change from baseline to Day28
change in the hydration rate
hydration rate before and after product use with a Corneometer
Change from baseline to Day28
Study Arms (1)
Toleriane Ultra
Participants are asked to apply the study product twice daily (morning and evening) at home for 28 days.
Interventions
The product developed to restore the natural skin barrier and rebalance skin immune system is a white cream and is applied on the face by a slight massage under normal conditions of use twice daily for 28 days.
Eligibility Criteria
participants meeting the inclusion and exclusion criteria and accepting the study constraints
You may qualify if:
- years old and above
- caucasian
- phototype I to IV
- participants presenting with an allergy ground
- participants having skin intolerance with cosmetic care
- participants who have not changed their cosmetic habits for less than 15 days
You may not qualify if:
- for women: pregnant or nursing or planning a pregnancy during the study
- cutaneous pathology on the studied zone
- use of topical or systemic treatment during the previous weeks liable to interfere with assessment of the cutaneous acceptability of the study product
- professional facial care during the study or within the previous month
- excessive exposure to sunlight or UV-rays within the previous month
- participant having undergone surgery under general anesthesia within the previous month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dermscan Poland Sp. z o. o.
Gdansk, 80-288, Poland
Related Publications (1)
Kerob D, Czermanska A, Karamon EM, Moga A, Lecerf G, Niore M, Le Dantec G, Le Floc'h C, Tan J. A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive Skin. Clin Cosmet Investig Dermatol. 2023 Jul 11;16:1787-1794. doi: 10.2147/CCID.S418483. eCollection 2023.
PMID: 37456802DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anna Czermanska
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2022
First Posted
August 4, 2022
Study Start
May 25, 2021
Primary Completion
September 28, 2021
Study Completion
September 28, 2021
Last Updated
August 4, 2022
Record last verified: 2022-08